MDS Experts Discuss Long-Term Findings From the COMMANDS Trial

In this segment, Thomas LeBlanc, MD, MA, of Duke Cancer Institute, Jamie Koprivnikar, MD, of Hackensack University Medical Center, and Andrew Brunner, MD, of Massachusetts General Hospital, delve into new data regarding the long-term efficacy of luspatercept in MDS.